Viral hepatitis: Treating hepatitis C in injection drug users. (Q51866104)

14 April 2018

title

Viral hepatitis: Treating hepatitis C in injection drug users. (English)

1 reference

14 April 2018

1 reference

1

Vincent Soriano

1 reference

14 April 2018

Lucía Gallego

2

1 reference

14 April 2018

language of work or name

English

0 references

publication date

3 September 2013

1 reference

14 April 2018

Nature Reviews Gastroenterology & Hepatology

published in

1 reference

14 April 2018

volume

10

1 reference

14 April 2018

page(s)

568-569

1 reference

14 April 2018

issue

10

1 reference

14 April 2018

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.165

exact match

0 references

cites work

Global control of hepatitis C: where challenge meets opportunity

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Hepatitis C treatment for injection drug users: a review of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

The changing face of hepatitis C in the new era of direct-acting antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.165

Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23999322

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23999322

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2013.165

1 reference

14 April 2018

PubMed ID

23999322

1 reference

14 April 2018